Quantcast

Latest pharmaceutical industry Stories

2014-08-05 08:33:41

Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide. ANN ARBOR, Mich. and DENVER, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Paradigm has announced today they have initiated genomic testing for Pharmatech's AccessPPM Cancer Registry. Pharmatech's AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials....

2014-08-05 08:33:22

Thomas Jefferson University Hospital is first site opened, more sites scheduled in August TORONTO AND CHICAGO, Aug. 5, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, and its subsidiary Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, today...

2014-08-05 08:33:16

MENLO PARK, Calif., Aug. 5, 2014 /PRNewswire/ -- TesoRx Pharma, LLC., a specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has closed $10 million in Series B-1 funding from existing and new private investors. The equity funding will be used to prepare for Phase 3 trials for TSX-002, a first-in-class oral formulation of unmodified testosterone, and to advance its pipeline and build out its...

2014-08-05 08:32:33

Conference Call and Webcast to Follow THE WOODLANDS, Texas, Aug. 5, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will release its second quarter 2014 financial results on Thursday, August 7, 2014 before the financial markets open. Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for the second...

2014-08-05 04:21:28

EATONTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") has signed an Exclusive Development, Supply & Distribution Agreement with Dexcel Ltd. ("Dexcel") for an Extended Release ANDA drug product. Dexcel will be responsible for the development, registration and manufacturing of the product, and Heritage Pharmaceuticals will be responsible for marketing and distribution in the U.S. The product generates generic annual U.S. sales of approximately $60...

2014-08-04 23:01:18

After a period of struggle, the Pharmaceuticals Wholesaling industry is set to return to growth as operators adapt their business models. For this reason, industry research firm IBISWorld has updated its report on Pharmaceuticals Wholesaling industry in Australia. Melbourne, Australia (PRWEB) August 05, 2014 Operators in the Pharmaceuticals Wholesaling industry in Australia are an important interface between local and international pharmaceutical manufacturers and the nation's 5,300...

2014-08-04 16:23:42

BOSTON, Aug. 4, 2014 /PRNewswire-USNewswire/ -- The Center for Information and Study on Clinical Research Participation (CISCRP) is pleased to announce the return of AWARE for All Boston, a free event designed to promote understanding and dialogue around clinical research participation. The event will be hosted at the Curry Student Center Ballroom at Northeastern University on Monday, October 27(th) from 5PM to 8PM and will feature free health screenings, informational exhibits,...

2014-08-04 12:30:57

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/restless_legs_syndrome_global_clinical_trials_review.html Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the...

2014-08-04 08:28:51

HAYWARD, Calif., Aug. 4, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a re-inspection of the Company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with seven inspectional observations, two of which are designated as repeat observations. The FDA did not provide any status or classification to these...

2014-08-04 04:21:17

CHENGDU, China, Aug. 4, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today provided further updates regarding the Company's Qionglai Facility (QLF). A series of testing runs with individual production lines have been performed at QLF in July following the equipment...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related